Shandong Sito Bio-technology Co Ltd Market Cap ($305.91 Million)
Market Cap & Net Worth: Shandong Sito Bio-technology Co Ltd (300583)
Shandong Sito Bio-technology Co Ltd market cap. Shandong Sito Bio-technology Co Ltd (SHE:300583) has a market capitalization of $305.91 Million (CN¥2.09 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #14460 globally and #4265 in its home market, demonstrating a -7.16% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Sito Bio-technology Co Ltd's stock price CN¥11.02 by its total outstanding shares 189702126 (189.70 Million). Also see Shandong Sito Bio-technology Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Shandong Sito Bio-technology Co Ltd Market Cap History (2017–2026)
Shandong Sito Bio-technology Co Ltd market cap history from 2017 to 2026. Data shows change from $680.34 Million to $305.91 Million (-10.99% CAGR). Check current stock price of Shandong Sito Bio-technology Co Ltd for real-time trading data and today's change.
Shandong Sito Bio-technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Sito Bio-technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300583 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.37x
Shandong Sito Bio-technology Co Ltd's market cap is 0.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $680.34 Million | $785.57 Million | $92.00 Million | 0.87x | 7.39x |
| 2018 | $551.38 Million | $1.05 Billion | $126.09 Million | 0.52x | 4.37x |
| 2019 | $573.38 Million | $965.80 Million | $55.31 Million | 0.59x | 10.37x |
| 2020 | $394.34 Million | $913.19 Million | -$179.81 Million | 0.43x | N/A |
| 2021 | $413.08 Million | $1.20 Billion | $36.21 Million | 0.34x | 11.41x |
| 2022 | $381.71 Million | $1.31 Billion | $41.97 Million | 0.29x | 9.10x |
| 2023 | $530.39 Million | $1.28 Billion | $45.60 Million | 0.41x | 11.63x |
| 2024 | $542.70 Million | $970.60 Million | -$88.77 Million | 0.56x | N/A |
| 2025 | $380.03 Million | $1.02 Billion | -$73.15 Million | 0.37x | N/A |
Competitor Companies of 300583 by Market Capitalization
Companies near Shandong Sito Bio-technology Co Ltd in the global market cap rankings as of November 6, 2026. Also see balance sheet size of Shandong Sito Bio-technology Co Ltd for a full breakdown of the balance sheet.
Key companies related to Shandong Sito Bio-technology Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Shandong Sito Bio-technology Co Ltd (2017–2026)
Market capitalization of Shandong Sito Bio-technology Co Ltd from 2017 to today. Between 2017 and today, Shandong Sito Bio-technology Co Ltd's market cap moved from $680.34 Million to $ 305.91 Million, with a yearly change of -10.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥305.91 Million | -19.50% |
| 2025 | CN¥380.03 Million | -29.97% |
| 2024 | CN¥542.70 Million | +2.32% |
| 2023 | CN¥530.39 Million | +38.95% |
| 2022 | CN¥381.71 Million | -7.60% |
| 2021 | CN¥413.08 Million | +4.75% |
| 2020 | CN¥394.34 Million | -31.23% |
| 2019 | CN¥573.38 Million | +3.99% |
| 2018 | CN¥551.38 Million | -18.95% |
| 2017 | CN¥680.34 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Shandong Sito Bio-technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $305.91 Million USD |
| MoneyControl | $305.91 Million USD |
| MarketWatch | $305.91 Million USD |
| marketcap.company | $305.91 Million USD |
| Reuters | $305.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Sito Bio-technology Co Ltd
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, bis-decyl alcohol (BA), neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, 16ß and 16… Read more